Brii Biosciences

About:

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

Website: https://www.briibio.com/

Top Investors: ARCH Venture Partners, Invesco, GIC, HongShan, 6 Dimensions Capital

Description:

Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company's medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.

Total Funding Amount:

$415M

Estimated Revenue Range:

$500M to $1B

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

2018-01-01

Contact Email:

BD(AT)briibio.com

Hub Tags:

Exited Unicorn

Founders:

Zhi Hong

Number of Employees:

101-250

Last Funding Date:

2021-03-23

IPO Status:

Public

© 2025 bioDAO.ai